Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Actinic Keratoses
Interventions
DRUG

Tirbanibulin

subjects receive 2,5 mgTirbanibulin in 250 mg ointment with daily administration of one single sachet on the left hand and 250mg ointment placebo on the right hand for 5 d in a single-blinded manner.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Almirall, SAS

INDUSTRY

lead

Medical University of Graz

OTHER